Emerging ocular imaging technologies may rapidly advance the ability to visualize structural and functional aspects of the human eye with unprecedented detail. This chapter highlights key emerging innovations including confocal scanning laser microscopy, Doppler holography, Laser Speckle Contact Imaging, adaptive optics, and two-photon excitation microscopy that may expand diagnostic and research capabilities in ophthalmology in the near future. CSLM offers high-resolution, in vivo imaging of corneal layers and nerve fibers, aiding in close evaluation of disorders. Doppler holography and LSCI may enable noninvasive retinal blood flow assessment, improving detection and monitoring of ischemic and vascular diseases, and AO technology corrects optical aberrations in real time to resolve individual photoreceptors and other retinal cells. Each modality presents unique advantages and limitations in resolution, depth, and clinical applicability. These technologies could represent a transformative leap toward earlier detection, improved disease understanding, and personalized treatment strategies in ophthalmology.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Emerging Ocular Imaging Technology

  • Michael P. Kelly

摘要

Emerging ocular imaging technologies may rapidly advance the ability to visualize structural and functional aspects of the human eye with unprecedented detail. This chapter highlights key emerging innovations including confocal scanning laser microscopy, Doppler holography, Laser Speckle Contact Imaging, adaptive optics, and two-photon excitation microscopy that may expand diagnostic and research capabilities in ophthalmology in the near future. CSLM offers high-resolution, in vivo imaging of corneal layers and nerve fibers, aiding in close evaluation of disorders. Doppler holography and LSCI may enable noninvasive retinal blood flow assessment, improving detection and monitoring of ischemic and vascular diseases, and AO technology corrects optical aberrations in real time to resolve individual photoreceptors and other retinal cells. Each modality presents unique advantages and limitations in resolution, depth, and clinical applicability. These technologies could represent a transformative leap toward earlier detection, improved disease understanding, and personalized treatment strategies in ophthalmology.